Company profile ADAG

Adagene Inc
adagene was co-founded by two serial entrepreneurs to power antibody discovery. its aim is to become the leading player in antibody discovery and engineering. it has developed a proprietary dynamic precision library (dpl) and is showcasing the power of the library with a unique pipeline of innovative antibody therapeutics that is advancing into clinical trials. adagene previous...ly has raised three series of financing with over $86 million. investors include f-prime capital (formerly fidelity biosciences), eight roads ventures china (formerly fidelity growth partners asia), 6 dimensions capital, gp healthcare capital, sequoia china, and new world tmt. for more information, please visit www.adagene.com. Show More
Quarter analysis & expected interestLast update: February 08 2024 12:57:15.

After 39 days of this quarter the interest is at 26.0. Based on that we can calculate that during remaining 52 days it will total up to 61.0.
Adagene expected interest is significantly higher compared to same quarter last year (+52.5%) but similar to previous quarter.

YearQ1Q2Q3Q4
20190
63
inf% QoQ
88
39.7% QoQ
9
-89.8% QoQ
2020 51
inf% YoY 466.7% QoQ
53
-15.9% YoY 3.9% QoQ
101
14.8% YoY 90.6% QoQ
42
366.7% YoY -58.4% QoQ
2021 220
331.4% YoY 423.8% QoQ
53
0.0% YoY -75.9% QoQ
115
13.9% YoY 117.0% QoQ
81
92.9% YoY -29.6% QoQ
2022 97
-55.9% YoY 19.8% QoQ
72
35.8% YoY -25.8% QoQ
61
-47.0% YoY -15.3% QoQ
48
-40.7% YoY -21.3% QoQ
2023 40
-58.8% YoY -16.7% QoQ
53
-26.4% YoY 32.5% QoQ
128
109.8% YoY 141.5% QoQ
70
45.8% YoY -45.3% QoQ
2024 26
-35.0% YoY -62.9% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Adagene search interest

There is not enough data for Adagene to provide correlation calculation

Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:57:16.

The average 5 years interest of Adagene was 5.64 per week.
The last year interest of Adagene compared to the last 5 years has changed by 1.24%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 53.91%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene ADG106 to provide analysis

Correlation between past revenue and Adagene ADG106 search interest

There is not enough data for Adagene ADG106 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene ADG106 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene ADG126 to provide analysis

Correlation between past revenue and Adagene ADG126 search interest

There is not enough data for Adagene ADG126 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene ADG126 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene ADG116 to provide analysis

Correlation between past revenue and Adagene ADG116 search interest

There is not enough data for Adagene ADG116 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene ADG116 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene jobs to provide analysis

Correlation between past revenue and Adagene jobs search interest

There is not enough data for Adagene jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene reviews to provide analysis

Correlation between past revenue and Adagene reviews search interest

There is not enough data for Adagene reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene ADG104 to provide analysis

Correlation between past revenue and Adagene ADG104 search interest

There is not enough data for Adagene ADG104 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene ADG104 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene clinical trials to provide analysis

Correlation between past revenue and Adagene clinical trials search interest

There is not enough data for Adagene clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene China to provide analysis

Correlation between past revenue and Adagene China search interest

There is not enough data for Adagene China to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene China to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Adagene -stock -company to provide analysis

Correlation between past revenue and Adagene -stock -company search interest

There is not enough data for Adagene -stock -company to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Adagene -stock -company to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ADAG
Earnings date: 2024-03-28 After close
Company name: Adagene Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-15T07:28:16.934Z

Reuters
A look at Indian billionaire Gautam Adani's businesses 

2026-05-12T12:30:00Z

GlobeNewswire
Adagene to Participate in Two Upcoming Investor Conferences

2026-04-27T14:35:39.598Z

Reuters
India's Adani Total Gas posts quarterly profit rise on demand boost

2026-04-17T20:01:00Z

GlobeNewswire
Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug's Potential as a Backbone Combination Therapy for Multiple Tumor Types

2026-04-14T11:00:00Z

GlobeNewswire
Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board

2026-04-06T11:55:31Z

Analyst Upgrades
Guggenheim Maintains Buy on Adagene, Raises Price Target to $10

2026-04-02T11:10:00Z

GlobeNewswire
Adagene Announces Pricing of US$70.0 Million Public Offering of ADSs

2026-04-02T11:01:00Z

GlobeNewswire
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte's TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)

2026-04-02T11:00:00Z

GlobeNewswire
Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA® (pembrolizumab) in Late-line Patients with Microsatellite Stable Colorectal Cancer Demonstrate Improved Durability of Response

2026-04-01T21:00:00Z

GlobeNewswire
Adagene Reports Full Year 2025 Financial Results and Provides Corporate Update

2026-02-17T14:27:16Z

GlobeNewswire
Adagene to Participate in Two Upcoming Investor Conferences

2026-01-23T13:00:00Z

GlobeNewswire
Adagene Provides Business Update and 2026 Objectives

2025-12-16T12:00:00Z

GlobeNewswire
Adagene Announces FDA Fast Track Designation for Muzastotug (ADG126)

2025-11-24T13:30:39Z

Analyst Upgrades
Guggenheim Initiates Coverage On Adagene with Buy Rating, Announces Price Target of $9

2025-11-13T12:00:00Z

GlobeNewswire
Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology